Selecting the Ideal Candidate for Anti-TNF Discontinuation in Crohn’s Disease, Dream or Reality?

Pierre N, Baiwir D, Huynh-Thu VA, et al. Discovery of Biomarker Candidates Associated With the Risk of Short-Term and Mid/Long-Term Relapse After Infliximab Withdrawal in Crohn’s Patients: A Proteomics-Based Study [published online ahead of print October 26, 2020]. Gut https://doi.org/10.1136/gutjnl-2020-322100

This entry was posted in News. Bookmark the permalink.